Summary
Ocean Medicines is a network of academic, research centres and SMEs across Europe, with proven experience in higher education, training and endowed with state-of-the art scientific and technical expertise and infrastructures. The aim is to establish a network of collaboration and knowledge-exchange between industrial and academic partners to further develop lead compounds from marine microorganisms having anticancer or anti-infective effects that have already been identified by the consortium. To achieve this goal a mobility programme will be set up to prepare a new generation of marine biodiscovery scientists that will be trained on how to isolate compounds from bioactive bacteria/microalgae and take these through to semi-industrial scale-up for further development and toxicity testing at the pre-clinical level. The Ocean Medicines programme also considers commercialization, innovation and entrepreneurship activities including how to start a new business and how to favor an industrial career to seconded researchers. The establishment of this international research network, with its synergistic effects, will significantly contribute to advance all of the involved Institutes/SMEs to the top level in the field of marine drug discovery.
What we do
SZN is involved in WP2 which targets species of bacteria and microalgae that produce bioactive metabolites with anticancer/anti-infective activities; these species will be bulk cultivated under different light/temperature/pH conditions to optimize production of active metobolites. Extracts and fractions will be further screened and chemically analyzed by the other partners.
Partners
SZN, IBP-CNR, SeaLife Pharma, eCoast, Epi-C, UiT, UNIABDN, MEDINA, UWC
Research Area
Marine Biotechnology
SZN role
Partner
Principal Investigator
Project Manager
Donatella De Pascale
Project lifetime
December 2015 - December 2019
Funding Institutions
European Commission, under the 7th Framework Programme
Personnel involved
Adrianna Ianora, Principal investigator
Giovanna Romano, Experienced researcher
